Clinical trial
Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis: Phase III Study, Controlled, Randomized, Crossed Over and Double Blind.
NCT05809414 is registered in ClinicalTrials.gov with Hospital San Carlos, Madrid as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis: Phase III Study, Controlled, Randomized, Crossed Over and Double Blind.
- Lead sponsor
- Hospital San Carlos, Madrid
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- November 28, 2022
- Completion date
- February 28, 2025
- Enrollment
- 144 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.